| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |